Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
manuela.merli@uniroma1.it
Manuela Merli
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
manuela.merli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting
JOURNAL OF CLINICAL MEDICINE
2024
Evolution of transplant oncology indications: a single-institution experience over 40 years
UPDATES IN SURGERY
2024
Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhosis
JOURNAL OF CLINICAL MEDICINE
2024
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis
JOURNAL OF HEPATOLOGY
2024
Reply to: “Reevaluating myosteatosis criteria in cirrhosis: Fluid and gender considerations”
JOURNAL OF HEPATOLOGY
2024
Reply to: “What references and what gold standard should be used to assess myosteatosis in chronic liver disease?”
JOURNAL OF HEPATOLOGY
2024
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis
JOURNAL OF HEPATOLOGY
2024
Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial
LIVER INTERNATIONAL
2024
Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections—Results from the ICA “Global Study” (EABCIR-Global Study)
HEPATOLOGY
2024
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements
HEPATOLOGY
2024
Sex disparities in acute-on-chronic liver failure: From admission to the intensive care unit to liver transplantation
DIGESTIVE AND LIVER DISEASE
2024
Development and external validation of a model to predict multidrug‐resistant bacterial infections in patients with cirrhosis
LIVER INTERNATIONAL
2024
Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver
EXPERT OPINION ON EMERGING DRUGS
2024
Impaired nutritional status, frailty and inadequate dietary intake : a reality still underdiagnosed in liver cirrhosis patients
DIGESTIVE AND LIVER DISEASE
2024
The crucial role of risk factors when dealing with hepatic Encephalopathy
METABOLIC BRAIN DISEASE
2024
Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients
Canadian Journal of Gastroenterology and Hepatology
2023
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study
FRONTIERS IN MEDICINE
2023
Sarcopenic obesity: recent consensus and clinical implications in patients with chronic liver disease
HEPATOBILIARY SURGERY AND NUTRITION
2023
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review
NUTRIENTS
2023
Influence of sex in alcohol-related liver disease: Pre-clinical and clinical settings
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
2023
1
2
3
4
5
6
7
8
seguente ›
ultima »
Progetti di Ricerca
Muscular alterations, cognitive deficit, movement disorders and risk of falls in cirrhotic patients: an observational, perspective and translational study in experimental models of liver disease and sarcopenia.
SARCOPENIA IN CORSO DI CIRROSI EPATICA: STUDIO CLINICO E TRANSLAZIONALE SUI MECCANISMI FISIOPATOLOGICI IN COLTURE DI CELLULE MUSCOLARI. SARCOPENIA IN LIVER CIRRHOSIS: CLINICAL AND TRANSLATIONAL STUDY ON PHYSIOPATHOLOGIC MECHANISM EVALUATED IN MUS...
EFFETTI DEL BETA-IDROSSI-BETA-METILBUTIRRATO SULLA SARCOPENIA IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO
EFFETTO DELLE MODIFICAZIONI DELLO STILE DI VITA E DELLO STIMOLO DELLA SINTESI PROTEICA CON HMB PER 12 SETTIMANE SULLA SARCOPENIA E SULLA ENCEFALOPATIA EPATICA NEL PAZIENTE CON CIRROSI EPATICA: STUDIO RANDOMIZZATO.
Gruppi di ricerca - Responsabile
Malnutrition and sarcopenia in patients with chronic advanced liver disease
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma